Literature DB >> 9156253

Allogeneic bone marrow transplantation for hypereosinophilic syndrome with advanced myelofibrosis.

A Sadoun1, L Lacotte, V Delwail, E Randriamalala, S Patri, P Babin, A Brizard, F Guilhot.   

Abstract

A 33-year-old man with an atypical course of hypereosinophilic syndrome including malignant hypercalcemia, osteolytic lesions and evolution into severe myelofibrosis was treated by allogeneic bone marrow transplantation after conditioning with cytoxan and total body irradiation. As the transplant was sex-mismatched, chimerism was studied by means of cytogenetic analysis and Y chromosomal DNA amplification by PCR assay. Long-term complete remission has been assessed by normalization of blood cell counts, magnetic resonance imaging and karyotypic analysis. A relapse was observed 40 months after transplantation. The patient remains alive 44 months post-BMT. This case report is compared with those reported in the literature.

Entities:  

Mesh:

Year:  1997        PMID: 9156253     DOI: 10.1038/sj.bmt.1700729

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  2 in total

1.  Osteolytic lesion in polycythemia vera: First report and review of literature.

Authors:  Verna Cheung; James England; Dawn Maze; Hassan Sibai
Journal:  EJHaem       Date:  2022-03-27

2.  Renal involvement in idiopathic hypereosinophic syndrome.

Authors:  Nathalie Shehwaro; Anne Lyse Langlois; Victor Gueutin; Hassane Izzedine
Journal:  Clin Kidney J       Date:  2013-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.